Detection of hemophagocytic extremely multinucleated giant plasma cells after rituximab/low-dose lenalidomide treatment in CD20+ multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Detection of hemophagocytic extremely multinucleated giant plasma cells after rituximab/low-dose lenalidomide treatment in CD20+ multiple myeloma

Published:2019-02-05 Issue:9 Volume:60 Page:2331-2333
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Schelker Roland Christian¹,Grube Matthias¹,Reichle Albrecht¹,Wagner Beate²,Herr Wolfgang¹,Evert Matthias³,Vogelhuber Martin¹

Affiliation:

1. Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg, Germany;

2. Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Regensburg, Regensburg, Germany;

3. Department of Pathology, University Hospital of Regensburg, Regensburg, Germany

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1571200

Reference11 articles.

1. Anti-CD20 monoclonal antibody therapy in multiple myeloma

2. CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients?

3. Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells

4. Relapse of Aggressive Myeloma after Complete Remission in Secondary Acute Leukemia: Coincidence or Consequence?

5. MULTILOBULATED, MULTINUCLEATED MULTIPLE MYELOMA

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD20 antibody treatment for B-cell malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma;Journal of Clinical Laboratory Analysis;2022-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3